We are live on ! Find out more
VIRS

Pacer BioThreat Strategy ETF
VIRS

Delisted

VIRS was delisted on the 10th of October, 2024.

Back to rankings

3 hedge funds and large institutions have $1.16M invested in Pacer BioThreat Strategy ETF in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

25% less funds holding

Funds holding: 4 → 3 (-1)

73% less capital invested

Capital invested by funds: $4.25M → $1.16M (-$3.09M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Osaic Holdings
Osaic Holdings
Arizona
+$14.9K
2
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$9.73K

Top Sellers

Rank Fund Capital Flow
1
IAIM
International Assets Investment Management
Florida
-$3.05M
2
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$75.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$797K -$75.6K -2,688 -9%
Cambridge Investment Research Advisors
2
Cambridge Investment Research Advisors
Iowa
$310K +$9.73K +346 +3%
Osaic Holdings
3
Osaic Holdings
Arizona
$51K +$14.9K +531 +41%
IAIM
4
International Assets Investment Management
Florida
– -$3.05M -108,640 Closed

VIRS Hedge Fund Activity: Q4 2020 in Review

3 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q4 2020, worth a combined $1.16M — down 73% from $4.25M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of VIRS and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.

The largest buyer was Osaic Holdings, adding an estimated $14.9K. The largest seller was International Assets Investment Management, exiting entirely with an estimated $3.05M sold.

  • 3 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q4 2020, down from 4 in Q3 2020.
  • Funds reported $1.16M of Pacer BioThreat Strategy ETF stock for Q4 2020, down 73% quarter-over-quarter.
  • 0 funds opened new Pacer BioThreat Strategy ETF positions in Q4 2020 and 1 closed out, a net change of -1 holder.
  • The largest Pacer BioThreat Strategy ETF buyer in Q4 2020 was Osaic Holdings, an estimated $14.9K added.
  • The largest Pacer BioThreat Strategy ETF seller in Q4 2020 was International Assets Investment Management, an estimated $3.05M sold.

Based on aggregated 13F filings for Q4 2020.